Author:
Neugroschl Judith,Sano Mary
Publisher
Springer Science and Business Media LLC
Subject
Clinical Neurology,General Neuroscience
Reference72 articles.
1. Barten DM, Albright CF: Therapeutic strategies for Alzheimer’s disease. Mol Neurobiol 2008, 37:171–186.
2. Nicoll JA, Wilkinson D, Holmes C, et al.: Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat Med 2003, 9:448–452.
3. Gilman S, Koller M, Black RS, et al.: Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. Neurology 2005, 64:1553–1562.
4. Elan: Elan and Wyeth to Initiate Phase 3 Clinical Trial of Bapineuzumab (AAB-001) in Alzheimer’s Disease. Available at http://www.elan.com/news/2007/20070521.asp . Accessed June 23, 2009.
5. Wyeth: Elan and Wyeth Announce Encouraging Top-Line Results from Phase 2 Clinical Trial of Bapineuzumab for Alzheimer’s Disease. Available at http://www.wyeth.com/news?nav=display&navTo=/wyeth_html/home/news/pressreleases/2008/1213683456273.html . Accessed June 23, 2009.
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献